共被期刊论文引用了2次
您的检索式：您选中1篇文献正在查看引证文献汇总
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: A systematic review显示文摘BACKGROUND Hepatocellular carcinoma(HCC)is a frequent cause of cancer related death globally.Neutrophil to lymphocyte ratio(NLR)and albumin bilirubin(ALBI)grade are emerging prognostic indicators in HCC.AIM To study published literature of NLR and ALBI over the last five years,and to validate NLR and ALBI locally in our centre as indicators of HCC survival.METHODS A systematic review of the published literature on PubMed of NLR and ALBI in HCC over the last five years.The search followed the guidelines of the preferred reporting items for systematic reviews and meta-analyses.Additionally,we also investigated HCC cases between December 2013 and December 2018 in our centre.RESULTS There were 54 studies describing the relation between HCC and NLR and 95 studies describing the relation between HCC and ALBI grade over the last five years.Our local cohort of patients showed NLR to have a significant negative relationship to survival(P=0.011).There was also significant inverse relationship between the size of the largest HCC nodule and survival(P=0.009).Median survival with alpha fetoprotein(AFP)<10 KU/L was 20 mo and with AFP>10 KU/L was 5 mo.We found that AFP was inversely related to survival,this relationship was not statically significant(P=0.132).Mean survival for ALBI grade 1 was 37.7 mo,ALBI grade 2 was 13.4 months and ALBI grade 3 was 4.5mo.ALBI grades performed better than Child Turcotte Pugh score in detecting death from HCC.CONCLUSION NLR and ALBI grade in HCC predict survival better than the conventional alpha fetoprotein.ALBI grade performs better than Child Turcotte Pugh score.These markers are done as part of routine clinical care and in cases of normal alpha fetoprotein,these markers could give a better understanding of the patient disease progression.NLR and ALBI grade could have a role in modified easier to learn staging and prognostic systems for HCC. | Ayman Bannaga Ramesh P Arasaradnam | 2020 | World Journal of Gastroenterology2020，26，33： | 2 |
| 2 | 超声引导下改良微波消融治疗原发性肝癌的临床疗效评估显示文摘目的:探索超声引导下改良微波消融治疗原发性肝癌的疗效、免疫功能及对患者血清甲胎蛋白(AFP)和血管内皮生长因子(VEGF)水平的影响。方法:选取医院收治的90例原发性肝癌患者,根据治疗方案的不同将其分为对照组和观察组,每组45例。对照组采用直接瘤体微波消融治疗,观察组采用超声引导下改良微波消融治疗,对比两组疾病控制率(DCR)、并发症发生率,以及各时间段血清指标、免疫指标及VEGF水平。结果:两组T淋巴细胞亚群CD8^(+)、CD4^(+)和自然杀伤(NK)细胞比较差异无统计意义,重复测量方差分析,两组VEGF蛋白值不同时点、交互及组间比较差异有统计学意义(F=8024.415,F=141.449,F=56.377;P<0.05)。两两比较中,观察组治疗后7 d和14 d的谷草转氨酶(AST)、谷丙转氨酶(ALT)、AFP以及VEGF等蛋白值均优于对照组,差异有统计学意义(t_(7 d)=10.229,t=4.579,t=16.077,t=7.197;t_(14 d)=9.916,t=12.118,t=15.499,t=11.947;P<0.05),观察组DCR(91.11%)高于对照组(73.33%),并发症发生率低于对照组,差异有统计学意义(χ^(2)=4.865,χ^(2)=4.406;P<0.05)。结论:对原发性肝癌患者实施超声引导下改良微波消融治疗效果显著,可提高治疗安全性,改善血清AFP、VEGF水平,恢复免疫功能。 | 巫晓伟 王渝洲 蒋辉 | 2022 | 中国医学装备2022，19，4： | 2 |
您所在的机构暂未开通此部分的功能，请联系管理员